5 marker metabolite panel for pancreatic ductal adenocarcinoma (PDAC)

Aliases
  • 5 marker metabolite panel
  • 5 marker metabolite panel for pancreatic ductal adenocarcinoma (PDAC)
  • 5-marker metabolite panel
  • 5-marker metabolite panel for pancreatic ductal adenocarcinoma (PDAC)
Description
A five metabolite (acetylspermidine, diacetylspermine, an indole-derivative, and two lysophosphatidylcholines) plasma metabolite panel for the detection of early-stage pancreatic ductal adenocarcinoma (PDAC).
Attributes
QA State
Under Review
Type
Metabolomic
HGNC Name
Certifications
  • None
QA State for Pancreas
Under Review

 Non-Public Biomarker

Organ-specific information for some biomarkers are currently being annotated or are "under review". Logging in may give you privileges to view additional information. Contact the Informatics Center if you believe you should have access.

 Non-Public Biomarker

Organ-specific information for some biomarkers are currently being annotated or are "under review". Logging in may give you privileges to view additional information. Contact the Informatics Center if you believe you should have access.

 Non-Public Biomarker

Organ-specific information for some biomarkers are currently being annotated or are "under review". Logging in may give you privileges to view additional information. Contact the Informatics Center if you believe you should have access.

 Non-Public Biomarker

Organ-specific information for some biomarkers are currently being annotated or are "under review". Logging in may give you privileges to view additional information. Contact the Informatics Center if you believe you should have access.

 Non-Public Biomarker

Organ-specific information for some biomarkers are currently being annotated or are "under review". Logging in may give you privileges to view additional information. Contact the Informatics Center if you believe you should have access.